November 14, 2024 Maria Dranishnikova Freedom Broker raises Viemed target price amid growing sleep therapy market
November 1, 2024 Maria Dranishnikova Eight small-cap stocks that stand to profit from a rapidly aging U.S.
October 30, 2024 Maria Dranishnikova Motley Fool highlights three small caps that could ‘trounce’ the S&P 500 on five-year horizon
October 28, 2024 Maria Dranishnikova The Motley Fool highlights two small caps with ‘far more’ upside than the Magnificent Seven
October 28, 2024 Maria Dranishnikova Royce Premier Fund reveals biggest third-quarter contributing and detracting stocks
October 25, 2024 Maria Dranishnikova EF Hutton sees over 600% upside in biotech small cap ImmunityBio
October 21, 2024 Maria Dranishnikova Morgan Stanley spotlights 10 small-cap stocks with at least 50% upside
October 17, 2024 Maria Dranishnikova Freedom Finance analyst highlights two small caps for risk-tolerant investors
October 15, 2024 Maria Dranishnikova Pickup in M&A activity bodes well for small caps — Jefferies analyst
October 14, 2024 Maria Dranishnikova The Motley Fool spotlights three small caps to invest in right now
October 14, 2024 Maria Dranishnikova Federated Hermes analyst names four alternatives to Big Tech stocks
October 9, 2024 Maria Dranishnikova Freedom Finance analyst spotlights two small caps with big potential
October 7, 2024 Maria Dranishnikova Lazard strategist says small caps at an ‘inflection point’ amid Fed pivot
October 7, 2024 Maria Dranishnikova Zacks SCR sees massive upside in vaccine maker Soligenix amid Marburg virus outbreak
October 3, 2024 Maria Dranishnikova Freedom spotlights five small-cap stocks with third-quarter returns over 100%
October 1, 2024 Maria Dranishnikova Wells Fargo sees ‘compelling opportunity’ for near-term small-cap trade
September 11, 2024 Maria Dranishnikova Micro-cap Tonix Pharmaceuticals massively undervalued amid monkeypox outbreak — Zacks
September 9, 2024 Maria Dranishnikova Zacks spotlights three stocks poised to benefit from booming tech services market
September 3, 2024 Maria Dranishnikova Insider Monkey names seven AI penny stocks most popular with hedge funds
September 2, 2024 Maria Dranishnikova Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued
August 29, 2024 Maria Dranishnikova Small caps and the U.S. election: How investors can win in the home stretch